Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Saigao Biotechnology is a leading Chinese high-tech enterprise specializing in the research, development, and large-scale production of functional sugar alcohols and dietary fibers. The company is a major global supplier of health-oriented sweeteners, including erythritol, xylitol, maltitol, and isomalto-oligosaccharides, which serve as low-calorie alternatives to traditional sugars. Its products are widely utilized in the pharmaceutical, food, and healthcare industries to address metabolic health concerns such as diabetes and obesity. Saigao operates advanced manufacturing facilities and maintains a strong focus on industrial biotechnology to optimize fermentation and purification processes. The company is recognized for its contribution to the "sugar-free" movement and its role in the global supply chain for functional health ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SAIGAO.